Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BioForm Dermal Filler PMAs Up For FDA Panel Review In August

This article was originally published in The Gray Sheet

Executive Summary

BioForm Medical's premarket approval applications for a dermal filler intended to treat both run-of-the-mill wrinkles and HIV-related facial fat loss will be reviewed by FDA's General & Plastic Surgery Devices Panel Aug. 24

You may also be interested in...



FDA Approves BioForm’s Radiesse Dermal Filler For HIV, Cosmetic Indications

BioForm says it will likely go public within the next year following approval of its Radiesse dermal filler for the cosmetic treatment of nasolabial folds and facial wasting in patients with HIV

FDA Approves BioForm’s Radiesse Dermal Filler For HIV, Cosmetic Indications

BioForm says it will likely go public within the next year following approval of its Radiesse dermal filler for the cosmetic treatment of nasolabial folds and facial wasting in patients with HIV

Radiesse Dermal Filler Gets Two Approval Recommendations From FDA Panel

BioForm Medical's Radiesse dermal filler device went two for two Aug. 24, with an FDA advisory panel recommending approval of the product both as a treatment for abnormal facial fat loss in people with HIV and as a cosmetic remedy for facial wrinkles

UsernamePublicRestriction

Register

OM006145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel